| Ageing hallmarks exhibit organ-specific temporal signatures N Schaum, B Lehallier, O Hahn, R Pálovics, S Hosseinzadeh, SE Lee, ... Nature, 1-7, 2020 | 984* | 2020 |
| The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans The Tabula Sapiens Consortium*, RC Jones, J Karkanias, MA Krasnow, ... Science 376 (6594), eabl4896, 2022 | 423 | 2022 |
| AXL-driven EMT state as a targetable conduit in cancer J Antony, RYJ Huang Cancer research 77 (14), 3725-3732, 2017 | 165 | 2017 |
| The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype–specific therapeutic target for ovarian cancer J Antony, TZ Tan, Z Kelly, J Low, M Choolani, C Recchi, H Gabra, ... Science signaling 9 (448), ra97-ra97, 2016 | 111 | 2016 |
| Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention J Antony, JP Thiery, RYJ Huang Physical biology 16 (4), 041004, 2019 | 68 | 2019 |
| Applications of the chick chorioallantoic membrane as an alternative model for cancer studies PY Chu, APF Koh, J Antony, RYJ Huang Cells Tissues Organs 211 (2), 222-237, 2022 | 50 | 2022 |
| The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer J Antony, E Zanini, Z Kelly, TZ Tan, E Karali, M Alomary, Y Jung, K Nixon, ... EMBO reports 19 (8), e45670, 2018 | 38 | 2018 |
| The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR-and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer E Zanini, LS Louis, J Antony, E Karali, IS Okon, AB McKie, S Vaughan, ... Molecular Cancer Therapeutics 16 (10), 2246-2256, 2017 | 31 | 2017 |
| LEFTY1 is a dual-SMAD inhibitor that promotes mammary progenitor growth and tumorigenesis M Zabala, NA Lobo, J Antony, LS Heitink, GS Gulati, J Lam, ... Cell Stem Cell 27 (2), 284-299. e8, 2020 | 14 | 2020 |
| Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions JR Birtley, M Alomary, E Zanini, J Antony, Z Maben, GC Weaver, ... Nature communications 10 (1), 3134, 2019 | 13 | 2019 |
| Targeting the AXL signaling pathway in ovarian cancer RYJ Huang, J Antony, TZ Tan, DSP Tan Molecular & Cellular Oncology 4 (2), e1263716, 2017 | 13 | 2017 |
| Usp16 modulates Wnt signaling in primary tissues through Cdkn2a regulation MFC Maddalena Adorno, Benedetta Nicolis di Robilant, Shaheen Shabbir ... Scientific Reports, 2018 | 11 | 2018 |
| Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers J Antony, E Zanini, JR Birtley, H Gabra, C Recchi Cancer Gene Therapy 28 (1), 18-26, 2021 | 9 | 2021 |
| Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer’s model F Reinitz, EY Chen, BN di Robilant, B Chuluun, J Antony, RC Jones, ... Elife 11, e66037, 2022 | 6 | 2022 |
| CDK19 is a Regulator of Triple-Negative Breast Cancer Growth RW Hsieh, AH Kuo, FA Scheeren, MA Zarnegar, SS Sikandar, J Antony, ... BioRxiv, 317776, 2018 | 3 | 2018 |
| Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis SS Sikandar, GS Gulati, J Antony, I Fetter, AH Kuo, WHD Ho, ... Science Advances 8 (45), eabm3548, 2022 | 2 | 2022 |
| Mouse lemur transcriptomic atlas elucidates primate genes, physiology, disease, and evolution Tabula Microcebus Consortium, C Ezran, S Liu, J Ming, LA Guethlein, ... bioRxiv, 2022.08. 06.503035, 2022 | 2 | 2022 |
| Mesenchymal tumor cells drive adaptive resistance of Trp53−/− breast tumor cells to inactivated mutant Kras LJ van Weele, SI Djomehri, S Cai, J Antony, SS Sikandar, D Qian, ... Molecular Oncology 16 (17), 3128-3145, 2022 | 1 | 2022 |
| LMO2 is critical for early metastatic events in breast cancer S Sikandar, J Antony, GS Gulati, AH Kuo, WH Dang Ho, S Das, CB Steen, ... bioRxiv, 2021.05. 26.443198, 2021 | 1 | 2021 |
| Modulating bone morphogenic protein (bmp) signaling in the treatment of alzheimer's disease EY Chen, F Reinitz, J Antony, MF Clarke, RC Jones US Patent App. 18/512,522, 2024 | | 2024 |
Ruby Huang Yun-JuProfessor, School of Medicine, National Taiwan UniversityVerified email at ntu.edu.tw
